Congenital Hypothyroidism Following Maternal I-131 Therapy in Unsuspected Pregnancy

Authors

  • Pawana Pusuwan Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University
  • Supawadee Likitmaskul Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
  • Mongkol Laohapensang Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University

Keywords:

Congenital hypothyroidism, radioiodine therapy, thyroid cancer, thyroid scan

Abstract

The authors report a term infant with congenital hypothyroidism following maternal radioiodine (I-131) treatment
for papillary thyroid cancer in unsuspected pregnancy. The woman received 150 millicuries (mCi) of I-131 during the
second trimester of pregnancy. Antenatal care was done in the other hospital without the awareness of previous I-131
treatment during pregnancy. The child presented with congenital hypothyroidism and recurring attacks of postprandial bilious
vomiting due to midgut malrotation and Ladd bands. This case reminds physicians of the importance of obtaining an
accurate menstrual history and providing information on conception in fertile woman before receiving I-131 treatment.

Downloads

Published

01-03-2009

How to Cite

Pusuwan, P., Likitmaskul, S. ., & Laohapensang, M. (2009). Congenital Hypothyroidism Following Maternal I-131 Therapy in Unsuspected Pregnancy. Siriraj Medical Journal, 61(2), 93–95. Retrieved from https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/246584

Issue

Vol. 61 No. 2 (2009): Mar-Apr

Section

Case Report

License

Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:

  • Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.